JP2002501015A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002501015A5 JP2002501015A5 JP2000528271A JP2000528271A JP2002501015A5 JP 2002501015 A5 JP2002501015 A5 JP 2002501015A5 JP 2000528271 A JP2000528271 A JP 2000528271A JP 2000528271 A JP2000528271 A JP 2000528271A JP 2002501015 A5 JP2002501015 A5 JP 2002501015A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1998/000345 WO1999037289A1 (en) | 1998-01-22 | 1998-01-22 | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002501015A JP2002501015A (ja) | 2002-01-15 |
| JP2002501015A5 true JP2002501015A5 (enExample) | 2005-12-22 |
Family
ID=8166843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000528271A Pending JP2002501015A (ja) | 1998-01-22 | 1998-01-22 | リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6544551B1 (enExample) |
| EP (1) | EP1051159B1 (enExample) |
| JP (1) | JP2002501015A (enExample) |
| KR (1) | KR100517399B1 (enExample) |
| CN (1) | CN100413492C (enExample) |
| AT (1) | ATE215817T1 (enExample) |
| AU (1) | AU756805B2 (enExample) |
| BR (1) | BR9814772A (enExample) |
| CA (1) | CA2318260C (enExample) |
| CZ (1) | CZ299229B6 (enExample) |
| DE (1) | DE69804865T2 (enExample) |
| DK (1) | DK1051159T3 (enExample) |
| ES (1) | ES2175663T3 (enExample) |
| HU (1) | HUP0004363A3 (enExample) |
| IL (1) | IL136196A (enExample) |
| NO (1) | NO20003674L (enExample) |
| NZ (1) | NZ505648A (enExample) |
| PL (1) | PL189654B1 (enExample) |
| PT (1) | PT1051159E (enExample) |
| SI (1) | SI1051159T1 (enExample) |
| SK (1) | SK284839B6 (enExample) |
| TR (1) | TR200001717T2 (enExample) |
| UA (1) | UA68372C2 (enExample) |
| WO (1) | WO1999037289A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7887817B2 (en) * | 2002-01-25 | 2011-02-15 | Aeterna Zentaris Gmbh | Process for preventing protozoal diseases |
| DE10203195A1 (de) * | 2002-01-25 | 2003-08-07 | Zentaris Ag | Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen |
| WO2003090757A1 (en) * | 2002-04-26 | 2003-11-06 | Rudolf Perl | Pharmaceutical compositions of phospholipid derivatives |
| US8383605B2 (en) | 2002-07-30 | 2013-02-26 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| KR20130016413A (ko) | 2002-07-30 | 2013-02-14 | 아에테르나 젠타리스 게엠베하 | 항종양 약제와 조합하여 사용하기 위한 알킬포스포콜린의 약물 제품 |
| CA2526586C (en) | 2003-09-09 | 2010-03-16 | Biogen International Gmbh | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| EP1799196B1 (en) | 2004-10-08 | 2016-06-22 | Forward Pharma A/S | Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| US8703179B2 (en) | 2006-05-11 | 2014-04-22 | Kimberly-Clark Worldwide, Inc. | Mucosal formulation |
| WO2010020276A1 (en) * | 2008-08-19 | 2010-02-25 | Orphanidis Pharma Research Gmbh | Treatment of coccidian parasites |
| MX2011011596A (es) | 2010-03-31 | 2012-02-01 | Keryx Biopharmaceuticals Inc | Perifosina y capecitabina como un tratamiento combinado para cancer. |
| MX2013005687A (es) | 2010-11-22 | 2013-10-17 | Dafra Pharma Res & Dev Bvba | Formas de dosificación sólida de oleil fosfocolina. |
| EP2723347B1 (en) | 2011-06-24 | 2019-09-04 | GRI Bio, Inc. | Prevention and treatment of inflammatory conditions |
| JP2016515602A (ja) * | 2013-04-08 | 2016-05-30 | アカデミッシュ メディッシュ セントラム | Ｉｂｄの治療に使用するためのミルテホシンまたはペリホシン |
| KR102193599B1 (ko) | 2014-09-17 | 2020-12-21 | 스티어라이프 인디아 프라이빗 리미티드 | 발포성 조성물 및 이의 제조방법 |
| CN104473941A (zh) * | 2014-12-20 | 2015-04-01 | 长沙佰顺生物科技有限公司 | 一种含有米替福新的药物制剂及其制备方法 |
| WO2017098481A1 (en) | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
| EP3965739B1 (en) * | 2019-04-12 | 2024-07-10 | Oblita Therapeutics BVBA | Tablet dosage formulations of oleyl phosphocholine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE888444C (de) * | 1951-11-10 | 1953-08-31 | Benckiser Gmbh Joh A | Verfahren zum Tablettieren von hygroskopischen Praeparaten |
| CA1338627C (en) * | 1985-12-04 | 1996-10-01 | Hansjorg Eibl | Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation |
| US4762658A (en) * | 1986-10-08 | 1988-08-09 | Central Soya Company, Inc. | Method of tableting of de-oiled phosphatides (lecithin) |
| US5290769A (en) * | 1989-09-27 | 1994-03-01 | Asta Pharma Aktiengesellschaft | Use of hexadecylphosphocholine for the treatment of psoriasis |
| EP0419998A3 (en) * | 1989-09-27 | 1991-10-23 | Asta Pharma Aktiengesellschaft | Use of alkylphosphonic acid derivatives for the treatment of psoriasis |
| DE4132344A1 (de) * | 1991-09-27 | 1993-04-01 | Max Planck Gesellschaft | Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis |
-
1998
- 1998-01-22 SI SI9830205T patent/SI1051159T1/xx unknown
- 1998-01-22 WO PCT/EP1998/000345 patent/WO1999037289A1/en not_active Ceased
- 1998-01-22 AT AT98904121T patent/ATE215817T1/de not_active IP Right Cessation
- 1998-01-22 TR TR2000/01717T patent/TR200001717T2/xx unknown
- 1998-01-22 JP JP2000528271A patent/JP2002501015A/ja active Pending
- 1998-01-22 CN CNB988125714A patent/CN100413492C/zh not_active Expired - Fee Related
- 1998-01-22 KR KR10-2000-7008029A patent/KR100517399B1/ko not_active Expired - Fee Related
- 1998-01-22 EP EP98904121A patent/EP1051159B1/en not_active Expired - Lifetime
- 1998-01-22 CZ CZ20002596A patent/CZ299229B6/cs not_active IP Right Cessation
- 1998-01-22 IL IL13619698A patent/IL136196A/en not_active IP Right Cessation
- 1998-01-22 HU HU0004363A patent/HUP0004363A3/hu unknown
- 1998-01-22 PL PL98342838A patent/PL189654B1/pl not_active IP Right Cessation
- 1998-01-22 CA CA002318260A patent/CA2318260C/en not_active Expired - Fee Related
- 1998-01-22 SK SK986-2000A patent/SK284839B6/sk unknown
- 1998-01-22 AU AU62121/98A patent/AU756805B2/en not_active Ceased
- 1998-01-22 ES ES98904121T patent/ES2175663T3/es not_active Expired - Lifetime
- 1998-01-22 DK DK98904121T patent/DK1051159T3/da active
- 1998-01-22 PT PT98904121T patent/PT1051159E/pt unknown
- 1998-01-22 UA UA2000084909A patent/UA68372C2/uk unknown
- 1998-01-22 NZ NZ505648A patent/NZ505648A/xx unknown
- 1998-01-22 BR BR9814772-2A patent/BR9814772A/pt not_active Application Discontinuation
- 1998-01-22 DE DE69804865T patent/DE69804865T2/de not_active Expired - Lifetime
-
2000
- 2000-07-18 NO NO20003674A patent/NO20003674L/no not_active Application Discontinuation
- 2000-07-24 US US09/624,890 patent/US6544551B1/en not_active Expired - Lifetime